Loading clinical trials...
Loading clinical trials...
To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanda Pharmaceuticals
NCT06803589 · Gastroparesis
NCT05229432 · Eosinophilic Gastritis, Gastroparesis, and more
NCT03876288 · Gastroparesis
NCT07287943 · Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I
NCT07324785 · Diabetic Gastroparesis
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Peoria, Arizona
Vanda Investigational Site
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions